0001104659-24-071247.txt : 20240613 0001104659-24-071247.hdr.sgml : 20240613 20240613160119 ACCESSION NUMBER: 0001104659-24-071247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLEIFER LEONARD S CENTRAL INDEX KEY: 0001218629 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 241041165 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 tm2417175-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-11 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001218629 SCHLEIFER LEONARD S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 Bd. Co-Chair, President & CEO 1 Common Stock 157552 I 2023 GRAT Common Stock 5932 I By 401(k) Plan Common Stock 2024-06-11 4 S 0 7321 1015.28 D 56877 I By Trust Common Stock 2024-06-11 4 S 0 1743 1016.04 D 55134 I By Trust Common Stock 2024-06-12 4 S 0 14879 1015.30 D 40255 I By Trust Common Stock 2024-06-12 4 S 0 270 1016.62 D 39985 I By Trust Common Stock 466877 D Common Stock 2024-06-12 4 C 0 1000 0.00 A 1000 I by Trust for Son Common Stock 2024-06-12 4 S 0 1000 1025.27 D 0 I by Trust for Son Class A Stock 0.00 2024-06-12 4 C 0 1000 0.00 D Common Stock 1000 14775 I by Trust for Son Class A Stock 0.00 Common Stock 1710790 1710790 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024. Represents volume-weighted average price of sales of 7,321 shares of common stock of Regeneron Pharmaceuticals, Inc. (the "Company") on June 11, 2024 at prices ranging from $1,015.00 to $1,015.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price. Represents volume-weighted average price of sales of 1,743 shares of Company stock on June 11, 2024 at prices ranging from $1,016.04 to $1,016.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price. Represents volume-weighted average price of sales of 14,879 shares of Company stock on June 12, 2024 at prices ranging from $1,015.00 to $1,015.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price. Represents volume-weighted average price of sales of 270 shares of Company stock on June 12, 2024 at prices ranging from $1,016.10 to $1,016.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price. Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 12, 2024 at prices ranging from $1,025.00 to $1,025.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price. Class A Stock of the Company converts to common stock of the Company on a one-to-one basis upon certain events or upon election of the shareholder. These shares of Class A Stock are presently convertible and such conversion feature does not expire. /s/**Leonard S. Schleifer 2024-06-13